Element Capital Management LLC Otonomy, Inc. Transaction History

Element Capital Management LLC

  • $1.29 Trillion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019
SELL
$1.51 - $2.93 $62,841 - $121,937
-41,617 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$2.6 - $3.95 $152,958 - $232,378
-58,830 Reduced 58.57%
41,617 $114,000
Q2 2018

Aug 14, 2018
BUY
$3.7 - $4.75 $371,653 - $477,123
100,447 New
100,447 $387,000

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email